Tag Archives: Monash Institute of Pharmaceutical Sciences

Potential treatment uncovered for chronic disease

A recent study published in Nature has revealed that a protein compound called IC7Fc has the potential to improve glucose metabolism, prevent weight gain and loss of muscle mass. The study suggests that this compound could therefore become an effective treatment for chronic conditions, including diabetes, obesity and loss of …

Read More »

Can new polymyxin antibiotic tackle superbugs?

The development of the new polymyxin is needed to meet an increasingly urgent healthcare need and Monash University today announced the grant of an exclusive licence of its portfolio of proprietary synthetic polymyxin antibiotics to a US-based biopharmaceutical company. The company, Qpex Biopharma is focused on developing new antibiotics to …

Read More »